首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC DETERMINATION OF CEFPODOXIME PROXETIL IN PURE AND TABLET DOSAGE FORMS THROUGH ION-PAIR COMPLEX FORMATION USING BROMOTHYMOL BLUE
【24h】

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC DETERMINATION OF CEFPODOXIME PROXETIL IN PURE AND TABLET DOSAGE FORMS THROUGH ION-PAIR COMPLEX FORMATION USING BROMOTHYMOL BLUE

机译:分光光度法通过溴对酚蓝离子对络合物分光光度法测定纯净和片剂剂量形式中的头孢泊肟酯的研制和验证

获取原文
           

摘要

Objective: A simple, direct and accurate spectrophotometric method has been developed for the determination of cefpodoxime proxetil (CEFP) in pure and pharmaceutical formulations by complex formation with bromothymol blue (BTB). Methods: The method involves the formation of yellow ion-pair complexes between BTB reagent and CEFP in chloroform. The two formed complexes ([CEFP]: [BTB] and [CEFP]: [BTB] 2 ) have maximum absorption at l max 422 nm. The proposed method was validated for specificity, linearity, precision and accuracy, repeatability, sensitivity (LOD and LOQ) and robustness with an average recovery of 99.0-101.4%. Results: The formed complex ([CEFP]: [BTB] 2 ) was measured against the reagent blank prepared in the same manner. Variables were studied in order to optimize the reaction conditions. Molar absorptivity (e) for two complexes were 8100 and 12600 L. mol -1 . cm -1 , respectively. Beer’s law was obeyed in the concentration range of 0.5576-55.760 μg/ml in the present of 1x10 -3 mol/l of BTB with good correlation coefficient (R 2 = 0.9995). The relative standard deviation did not exceed 4.7%. The limit of detection (LOD) and the limit of quantification (LOQ) were 0.088 and 0.27 μg/ml, respectively. Conclusion: The developed method is applicable for the determination of CEFP in pure and different dosage forms with the average assay of marketed formulations 99.5 to 103.2%, and the results are in good agreement with those obtained by the RP-HPLC reference method.
机译:目的:建立了一种简单,直接,准确的分光光度法,通过与溴百里酚蓝(BTB)的络合形成来测定纯制剂和药物制剂中的头孢泊肟酯(CEFP)。方法:该方法涉及BTB试剂与CEFP在氯仿中形成黄色离子对络合物。所形成的两个复合物([CEFP]:[BTB]和[CEFP]:[BTB] 2)在l max 422 nm处具有最大吸收。所提方法的特异性,线性,精密度和准确性,可重复性,灵敏度(LOD和LOQ)和鲁棒性均得到验证,平均回收率为99.0-101.4%。结果:针对以相同方式制备的试剂空白测量形成的复合物([CEFP]:[BTB] 2)。研究了变量以优化反应条件。两种复合物的摩尔吸收率(e)为8100和12600 L. mol -1。 cm -1。在存在1x10 -3 mol / l的BTB时,在0.5576-55.760μg/ ml的浓度范围内遵守比尔定律,且相关系数良好(R 2 = 0.9995)。相对标准偏差不超过4.7%。检测限(LOD)和定量限(LOQ)分别为0.088和0.27μg/ ml。结论:所开发的方法适用于纯和不同剂型中CEFP的测定,市售制剂的平均含量为99.5%至103.2%,结果与RP-HPLC参考方法获得的结果吻合良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号